<DOC>
	<DOCNO>NCT00811434</DOCNO>
	<brief_summary>Pediatric patient chronic liver disease may Minimal Hepatic Encephalopathy ( MHE ) cause change behavior , intelligence neurological function.By utilize cognitive developmental test determine patient MHE . If , trial 3 month blind placebo Lactulose treatment follow washout period treatment . At time patient re-tested begin another three month period switch opposite treatment first 3 months.Final cognitive/developmental test determine Lactulose treatment effect MHE .</brief_summary>
	<brief_title>Study Lactulose Children With Chronic Liver Disease</brief_title>
	<detailed_description>In addition , serum ammonia level obtain begin study , post-washout end study evaluate Lactulose effect serum ammonia .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Brain Diseases</mesh_term>
	<mesh_term>Hepatic Encephalopathy</mesh_term>
	<mesh_term>Lactulose</mesh_term>
	<criteria>Clinical diagnosis MHE result cognitive , developmental testing , pediatric pt . cirrhosis evidence imaging/biopsy patient neurological , psychiatric unstable medical condition may contribute impaired cognitive function . patient know hear vision difficulty . patient speak English exclude .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>encephalopathy</keyword>
	<keyword>pediatric liver disease</keyword>
	<keyword>pediatric cirrhosis</keyword>
	<keyword>serum ammonia level</keyword>
</DOC>